Disclosed are immunostimulatory fusion proteins and methods for generating protective DC-induced, T cell-mediated immune responses in vitro and in vivo. The immunostimulatory fusion proteins comprise a polypeptide antigen component and an immunostimulatory component derived from the intracellular domain of the HER-2 protein. Also disclosed are immunostimulatory compositions comprising dendritic cells pulsed with such an immunostimulatory fusion protein and methods for immunotherapy using the compositions.

 
Web www.patentalert.com

< Recombinant feline herpesvirus type 1 and polyvalent vaccine using the same

> Heterocyclic antiviral compounds

> Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors

~ 00576